Filing Details
- Accession Number:
- 0001453687-20-000133
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-12-16 16:31:17
- Reporting Period:
- 2020-12-14
- Accepted Time:
- 2020-12-16 16:31:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1453687 | Selecta Biosciences Inc | SELB | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1284500 | G Peter Traber | C/O Selecta Biosciences, Inc. 65 Grove Street Watertown MA 02472 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-12-14 | 40,000 | $3.24 | 40,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average price. The shares were purchased in multiple transactions at per share prices ranging from $3.165 to $3.28. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.